Who
Bernard Denoyer
Director
Company insider
Files Form 4 as: Director, OKYO Pharma; Senior Vice President, Finance, Synergy Pharmaceuticals; Chief Financial Officer, Hepion Pharmaceuticals; Senior Vice President, Finance, Callisto Pharmaceuticals.
In numbers
- Trades disclosed
- 33
- Buys
- 2
- Sells
- 1
- Bought
- $46K
- Sold
- $75K
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 6 Dec 2011
- Last trade
- 8 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 10 Jun 2026 | OKYO OKYO Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | $6,4753,500 at $1.85 | filing |
| 8 Jun 2026filed 10 Jun 2026 | OKYO OKYO Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | $6,4753,500 at $1.85 | filing |
| 24 Jun 2016filed 27 Jun 2016 | Synergy Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 29 Sep 2015filed 30 Sep 2015 | Synergy Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 14 Sep 2015filed 16 Sep 2015 | Synergy Pharmaceuticals | SEC FORM 4 Code M | $34K10,000 at $3.40 | filing |
| 14 Sep 2015filed 16 Sep 2015 | Synergy Pharmaceuticals | SEC FORM 4 Sold | $75K10,000 at $7.50 | filing |
| 14 Sep 2015filed 16 Sep 2015 | Synergy Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 24 Jul 2015filed 28 Jul 2015 | Synergy Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 6 Dec 2014filed 9 Dec 2014 | Synergy Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —156,000 at $0.00 | filing |
| 10 Jun 2014filed 12 Jun 2014 | Synergy Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 23 May 2014filed 28 May 2014 | Synergy Pharmaceuticals | SEC FORM 4 Bought | $9,7252,500 at $3.89 | filing |
| 3 Apr 2014filed 4 Apr 2014 | Hepion Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 18 Feb 2014filed 20 Feb 2014 | Hepion PharmaceuticalsBiotechnology | SEC FORM 4 Code J | —1,030 | filing |
| 24 Jan 2014filed 28 Jan 2014 | Hepion Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 26 Nov 2013filed 26 Nov 2013 | Hepion Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 12 Jul 2013filed 17 Jul 2013 | Synergy Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 12 Jul 2013filed 16 Jul 2013 | Synergy Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 21 Jun 2013filed 24 Jun 2013 | Synergy Pharmaceuticals | SEC FORM 4 Bought | $36K7,500 at $4.78 | filing |
| 17 Jan 2013filed 22 Jan 2013 | Callisto Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —100,000 | filing |
| 17 Jan 2013filed 22 Jan 2013 | Callisto Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —75,000 | filing |
News
No headline names them, or the companies they trade most, lately.